Form D · Private Equity Fund

OrbiMed Asia Partners V, L.P.

New York, NY · CIK 0001920536

Offering snapshot reported Nov 28, 2022 · SEC filing

Reported sold: $652M
Investors reported: 68
Minimum accepted: $0
First sale: Apr 29, 2022

What changed?

Latest filing versus its linked predecessor, where available.

Reported investors0 → 68

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Nov 28, 2022	Amendment	$651,872,014	No comparison	68	SEC filing
Apr 28, 2022	Initial	Yet to sell	No comparison	0	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C, 3C.7
Duration over one year: No
Business combination: No

Sales commissions: $0 (estimated)
Finders' fees: $0 (estimated)
Form D file number: 021-443753

The total amount sold includes capital committed by the GPLP.

Paid based on percentage of committed capital of investors introduced by selling agent. Management fees will be offset by any such amounts paid by the Issuer. Such amounts do not reduce the offering proceeds available for investment.

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
J.P. Morgan Securities LLC	79
Wells Fargo Clearing Services, LLC	19616
Wells Fargo Advisors Financial Network, LLC	11025

Source: Form D, filed Nov 28, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

ORBIMED ASIA PARTNERS V, LP

Investment adviser: ORBIMED ADVISORS LLC

Gross asset value: $948M
Beneficial owners: 95
ADV minimum commitment: $1M

Reported in Form ADV on Aug 18, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator HEDGESERV (CAYMAN ) LTD. GEORGE TOWN, Cayman Islands Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor KPMG LLP NEW YORK, New York, United States

Custodian AFRAASIA BANK LIMITED PORT LOUIS, Mauritius Related to adviser: No

Custodian ICICI BANK LIMITED MUMBAI, India Related to adviser: No

Custodian JP MORGAN CHASE BANK, N.A. NEW YORK, New York, United States Related to adviser: No

Custodian SILICON VALLEY BANK NEWTON, Massachusetts, United States Related to adviser: No

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

KPMG LLP
PCAOB 185

JP MORGAN CHASE BANK, N.A.
LEI 7H6GLXDRUGQFU57RNE9

Filing source

Form ADV 2126532 · Aug 18, 2026 · Schedule D 7.B.(1), fund 805-1599250392

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Sven H. Borho	Director
Carl L. Gordon	Director
W. Carter Neild	Director
N/A Orbi Med Advisors V Limited	Executive
N/A Orbi Med Asia Gp V, L.P.	Executive
Sunny Sharma	Director
David G. Wang	Director

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

601 Lexington Avenue 54th Floor
New York, NY, 10022